SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Shin-Etsu Chemical Co., Ltd. (SHECY) trades at a trailing P/E of 0.2, forward P/E of 0.2. Trailing earnings yield is 625.00%, forward earnings yield 555.56%. PEG 0.04 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.04); earnings yield beats bond yields (625.00%).
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 625.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 83/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SHECY
Valuation Multiples
P/E (TTM)0.2
Forward P/E0.2
PEG Ratio0.04
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.03
EV/EBITDA0.0
Per Share Data
EPS (TTM)$134.64
Forward EPS (Est.)$120.55
Book Value / Share$0.00
Revenue / Share$645.75
FCF / Share$0.00
Yields & Fair Value
Earnings Yield625.00%
Forward Earnings Yield555.56%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$17.47 |
$1.28T |
$148.84B |
11.6% |
| 2017 |
$20.64 |
$1.24T |
$175.91B |
14.2% |
| 2018 |
$31.22 |
$1.44T |
$266.24B |
18.5% |
| 2019 |
$36.30 |
$1.59T |
$309.13B |
19.4% |
| 2020 |
$75.50 |
$1.54T |
$314.03B |
20.3% |
| 2021 |
$70.63 |
$1.5T |
$293.73B |
19.6% |
| 2022 |
$120.28 |
$2.07T |
$500.12B |
24.1% |
| 2023 |
$173.81 |
$2.81T |
$708.24B |
25.2% |
| 2024 |
$129.59 |
$2.41T |
$520.14B |
21.5% |
| 2025 |
$134.64 |
$2.56T |
$534.02B |
20.9% |
